• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Emerging COVID-19 vaccines: A rheumatology perspective.

作者信息

Byravan Swetha, Fardanesh Armin, Tahir Hasan, Moorthy Arumugam

机构信息

University Hospitals of Leicester NHS Trust, Leicester, UK.

Royal Free London NHS Foundation Trust, London, UK.

出版信息

Int J Rheum Dis. 2021 Feb;24(2):144-146. doi: 10.1111/1756-185X.14048.

DOI:10.1111/1756-185X.14048
PMID:33523564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8013514/
Abstract
摘要

相似文献

1
Emerging COVID-19 vaccines: A rheumatology perspective.新兴的新冠疫苗：风湿病学视角
Int J Rheum Dis. 2021 Feb;24(2):144-146. doi: 10.1111/1756-185X.14048.
2
Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.风湿科医师新加坡分会关于风湿性疾病患者接种 COVID-19 疫苗的建议。
Int J Rheum Dis. 2021 Jun;24(6):746-757. doi: 10.1111/1756-185X.14107. Epub 2021 May 10.
3
Number of Childhood and Adolescent Vaccinations Administered Before and After the COVID-19 Outbreak in Colorado.科罗拉多州 COVID-19 爆发前后儿童和青少年接种疫苗的数量。
JAMA Pediatr. 2021 Mar 1;175(3):305-307. doi: 10.1001/jamapediatrics.2020.4733.
4
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination.德国风湿病学会关于在SARS-CoV-2/COVID-19大流行背景下照顾炎性风湿性疾病患者的最新建议，包括COVID-19疫苗接种建议。
Z Rheumatol. 2021 Dec;80(Suppl 2):33-48. doi: 10.1007/s00393-021-01055-7. Epub 2021 Sep 7.
5
COVID-19 vaccination programme: a central role for primary care.2019冠状病毒病疫苗接种计划：初级保健的核心作用。
Br J Gen Pract. 2021 Jan 28;71(703):52-53. doi: 10.3399/bjgp21X714929. Print 2021.
6
What Are COVID-19 Vaccines?什么是新冠疫苗？
Am J Respir Crit Care Med. 2021 May 1;203(9):P22-P23. doi: 10.1164/rccm.2021C2.
7
[Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination].[德国风湿病学会关于在SARS-CoV-2/COVID-19大流行背景下照顾炎性风湿性疾病患者的最新建议，包括COVID-19疫苗接种建议]
Z Rheumatol. 2021 Aug;80(6):570-587. doi: 10.1007/s00393-021-01056-6.
8
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.风湿性和肌肉骨骼疾病患者对新型冠状病毒2型疫苗的犹豫态度：给风湿病学家的启示
Ann Rheum Dis. 2021 Jul;80(7):953-954. doi: 10.1136/annrheumdis-2021-220059. Epub 2021 Feb 23.
9
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.风湿病学大学教师对冠状病毒病-19（COVID-19）疫苗的看法：来自埃及的 vaXurvey 研究。
Rheumatol Int. 2021 Sep;41(9):1607-1616. doi: 10.1007/s00296-021-04941-0. Epub 2021 Jul 9.
10
COVID-19 vaccination in our transplant recipients: The time is now.新冠病毒疫苗在我们移植受者中的应用：现在是时候了。
J Heart Lung Transplant. 2021 Mar;40(3):169-171. doi: 10.1016/j.healun.2020.12.009. Epub 2021 Jan 2.

引用本文的文献

1
SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study.风湿性疾病患者对 SARS-CoV-2 疫苗的接受度：一项横断面研究。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4048-4056. doi: 10.1080/21645515.2021.1958611. Epub 2021 Aug 6.
2
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.风湿病学大学教师对冠状病毒病-19（COVID-19）疫苗的看法：来自埃及的 vaXurvey 研究。
Rheumatol Int. 2021 Sep;41(9):1607-1616. doi: 10.1007/s00296-021-04941-0. Epub 2021 Jul 9.

本文引用的文献

1
SARS-CoV-2 reinfection in two patients who have recovered from COVID-19.两名新冠肺炎康复患者出现新冠病毒二次感染。
Precis Clin Med. 2020 Sep 4;3(4):292-293. doi: 10.1093/pcmedi/pbaa031. eCollection 2020 Dec.
2
Elimination of COVID-19: what would it look like and is it possible?消除新冠病毒：会是什么样子以及是否可行？
Lancet Infect Dis. 2020 Sep;20(9):1005-1007. doi: 10.1016/S1473-3099(20)30633-2. Epub 2020 Aug 6.
3
Next-generation vaccine platforms for COVID-19.用于新型冠状病毒肺炎的下一代疫苗平台
Nat Mater. 2020 Aug;19(8):810-812. doi: 10.1038/s41563-020-0746-0.
4
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?新冠康复后临床复发的 COVID-19 症状：病毒复发、再感染还是炎症反弹？
J Infect. 2020 Nov;81(5):816-846. doi: 10.1016/j.jinf.2020.06.073. Epub 2020 Jun 30.
5
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.COVID-19 患者与风湿病患者的临床特征和结局：来自美国“热点地区”的一项比较队列研究。
Ann Rheum Dis. 2020 Sep;79(9):1156-1162. doi: 10.1136/annrheumdis-2020-217888. Epub 2020 May 26.
6
Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs.灭活流感疫苗在接受改善病情抗风湿药物治疗的自身免疫性风湿病中的有效性。
Rheumatology (Oxford). 2020 Dec 1;59(12):3666-3675. doi: 10.1093/rheumatology/keaa078.
7
Understanding vaccine acceptance and demand-and ways to increase them.了解疫苗的接受度和需求以及提高这些方面的方法。
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jan;63(1):32-39. doi: 10.1007/s00103-019-03063-0.
8
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials.基于水疱性口炎病毒的埃博拉病毒疫苗：从概念到临床试验。
Hum Vaccin Immunother. 2018;14(9):2107-2113. doi: 10.1080/21645515.2018.1473698. Epub 2018 Jun 18.
9
Herd immunity: history, theory, practice.群体免疫：历史、理论与实践。
Epidemiol Rev. 1993;15(2):265-302. doi: 10.1093/oxfordjournals.epirev.a036121.